Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy.

Area of Science:

• Microbiology
• Gastroenterology
• Virology

Background:

• Bacteriophages (viruses that infect bacteria) are increasingly studied for their role in gut homeostasis.
• They are explored as tools for microbiota engineering and as alternatives to antibiotics against resistant pathogens.
• Effective application requires bacteriophages to reach and eliminate target bacteria within the gut.

Purpose of the Study:

• To review the administration of bacteriophages targeting intestinal bacteria in mammalian experimental models.
• To assess the impact of bacteriophage administration on bacterial loads and treatment efficacy in the gut.

Main Methods:

• Systematic review of studies involving bacteriophage administration in mammalian models.
• Analysis of reported bacteriophage amplification within the gut.
• Evaluation of the impact on targeted bacterial loads and treatment outcomes.

Main Results:

• Bacteriophage amplification in the gut was frequently confirmed across studies.
• However, in most cases, this amplification did not significantly reduce the load of targeted bacteria.
• Treatment efficacy was highly variable, ranging from poor in asymptomatic carriage to high in intestinal disease models.

Conclusions:

• The variable efficacy of bacteriophage interventions in the gut highlights challenges in achieving consistent outcomes.
• The behavior of target bacteria and the specific animal model significantly influence treatment success.
• Further investigation into key parameters influencing bacteriophage efficacy is crucial before human clinical trials.